Atrium Health’s Sanger Heart & Vascular Institute first in the world to use implantable fish-skin grafting in reconstructive surgery


Atrium Health’s Sanger Heart & Vascular Institute has received a Center of Excellence designation from Kerecis®, a medical device manufacturer pioneering the use of fish skin and fatty acids in cellular therapy, tissue regeneration and protection.

Sanger Heart & Vascular Institute surgeon Dr. Hector Crespo Soto is the first physician in the world to use SurgiBind implantable reinforcement fish-skin commercially. With this designation, Crespo Soto and the team at Sanger Heart & Vascular Institute…

Previous Seattle biotech Ozette raises $26M round led by Madrona
Next Atrium Health Sanger Heart & Vascular Institute celebrates 700th heart transplant milestone

No Comment

Leave a reply

Your email address will not be published.